The global pharmaceutical contract development and manufacturing organization (CDMO) market is witnessing substantial growth, driven by the increasing outsourcing of drug development and manufacturing processes by pharmaceutical companies. As the complexity of drug development rises and cost pressures intensify, CDMOs are becoming essential partners in accelerating time-to-market and improving...

Market Overview & Size The global pharmaceutical CDMO industry has moved well past its early role as a low-cost manufacturing backup option — it is now a structural pillar of how new drugs reach patients. According to Grand View Research, the market was valued at USD 166.0 billion in 2025 and is estimated to reach USD 177.6 billion in 2026. From there, it is projected to climb to USD...